查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1720556

格林-巴利症候群(GBS)診斷的全球市場 - 市場規模，佔有率，趨勢，產業分析:檢查別，各最終用途，各地區 - 市場預測(2025年～2034年)

Guillain-Barre Syndrome Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Test, End Use, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 125 Pages | 商品交期: 最快1-2個工作天內

價格

預計到 2034 年，全球格林-巴利症候群 (GBS) 診斷市場規模將達到 1.9071 億美元。

格林-巴利症候群 (GBS) 的診斷需要結合臨床評估和神經傳導研究、腰椎穿刺等檢查，以確認是否存在這種影響週邊神經系統的罕見自體免疫疾病。

醫療診斷技術的進步正在推動 GBS 診斷市場的成長。更新、更先進的工具，例如高解析度神經傳導研究和改進的腰椎穿刺技術，使醫療保健專業人員能夠比以往更準確、更快速地診斷 GBS。這些進展正在降低誤診率，並減少可能導致患者病情惡化的治療延誤。此外，創新的診斷平台為患者和醫療保健專業人員提供了非侵入性、更快速、更經濟的治療方案，有助於有效識別和治療格林巴利症候群 (GBS)。這些持續的技術創新正在推動格林巴利症候群 (GBS) 診斷市場的擴張。

醫學研究資金的增加對格林-巴利症候群 (GBS) 診斷市場的趨勢產生了重大影響。政府、私人組織和醫療保健機構正在投入更多資源，用於研究格林-巴利綜合症 (GBS)、其病因以及提高診斷效率。這些投資正在推動新方法、工具和技術的開發，從而提高診斷準確性並縮短診斷時間。研究經費也加深了我們對格林-巴利症候群的理解，進而帶來更有效的檢測策略。格林巴利症候群研究的資助持續推動先進診斷解決方案的普及，使患者更容易獲得早期發現和治療。

格林-巴利症候群 (GBS) 診斷市場報告重點

從最終用途來看，由於醫院和診所擁有診斷格林巴利症候群 (GBS) 所需的資源，因此在 2024 年，醫院和診所佔據了格林巴利症候群 (GBS) 診斷市場的主導佔有率。

從檢測角度來看，腰椎穿刺細分市場預計將在預測期內成長最快，因為它是一項關鍵檢測，透過分析腦脊髓液中升高的蛋白質濃度來幫助診斷格林-巴利症候群。

由於北美擁有先進的醫療基礎設施和對罕見疾病的高度認知，北美在 2024 年佔據了 GBS 診斷市場的收入佔有率。

由於醫療基礎設施的改善和對罕見疾病認知度的提高，預計亞太地區將在預測期內佔據顯著佔有率。

全球市場的主要參與者包括Alpine Biomed，Bionen Medical Devices，Cadwell Industries, Inc，Deymed Diagnostic，EMS Biomedical，Medtronic plc，Natus Medical Incorporated，Neurosoft，Nihon Kohden Corporation，Rochester Electro-Medical, Inc.等。

本報告提供全球格林-巴利症候群(GBS)診斷市場相關調查，提供目前市場動態的詳細的考察，及未來市場成長相關分析。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球格林-巴利症候群(GBS)診斷市場考察

  • 市場概述
  • 格林-巴利症候群 (GBS) 診斷的市場動態
    • 推動因素與機遇
      • 老年人口不斷增加
      • 格林-巴利症候群 (GBS) 盛行率不斷上升
    • 限制與課題
      • 熟練勞動力短缺
  • PESTEL分析
  • 格林-巴利症候群(GBS)診斷市場最終用途趨勢
  • 價值鏈分析
  • COVID-19影響的分析

第5章 全球格林-巴利症候群(GBS)診斷市場:檢查別

  • 主要調查結果
  • 簡介
  • 腰椎穿刺
  • 神經傳導
  • 肌電圖檢驗
  • 其他

第6章 全球格林-巴利症候群(GBS)診斷市場:各最終用途

  • 主要調查結果
  • 簡介
  • 醫院·診療所
  • 診斷研究所
  • 其他

第7章 全球格林-巴利症候群(GBS)診斷市場:各地區

  • 主要調查結果
  • 簡介
    • 格林-巴利症候群(GBS)診斷市場分析:各地區(2020年～2034年)
  • 北美
    • 北美:試驗(2020年～2034年)
    • 北美:各最終用途(2020年～2034年)
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:試驗(2020年～2034年)
    • 歐洲:各最終用途(2020年～2034年)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他的歐洲
  • 亞太地區
    • 亞太地區:試驗(2020年～2034年)
    • 亞太地區:各最終用途(2020年～2034年)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他的亞太地區
  • 中東·非洲
    • 中東·非洲:試驗(2020年～2034年)
    • 中東·非洲:各最終用途(2020年～2034年)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他的中東·非洲
  • 南美
    • 南美:試驗(2020年～2034年)
    • 南美:各最終用途(2020年～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他的南美

第8章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 夥伴關係/合作/協定/公開

第9章 企業簡介

  • Alpine Biomed
  • Bionen Medical Devices
  • Cadwell Industries, Inc
  • Deymed Diagnostic
  • EMS Biomedical
  • Medtronic plc
  • Natus Medical Incorporated
  • Neurosoft
  • Nihon Kohden Corporation
  • Rochester Electro-Medical, Inc.
Product Code: PM5538

The Guillain-Barre syndrome (GBS) diagnostics market size is expected to reach USD 190.71 million by 2034, according to a new study by Polaris Market Research. The report "Guillain-Barre Syndrome Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Test (Lumber Puncture, Nerve Conduction, Electromyography, and Others), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Guillain-Barre Syndrome (GBS) diagnostics involves a combination of clinical evaluation and tests such as nerve conduction studies and lumbar puncture to confirm the presence of this rare autoimmune disorder affecting the peripheral nervous system.

Technological advancements in medical diagnostics are driving the GBS diagnostics market growth. Newer, more sophisticated tools such as high-resolution nerve conduction studies and improved lumbar punctures allow healthcare professionals to diagnose GBS more accurately and faster than before. These developments have reduced the chances of misdiagnosis, which delay treatment and worsen the patient's condition. Moreover, innovative diagnostic platforms now offer noninvasive, quicker, and more affordable options for both patients and healthcare providers, making it easier to identify and treat GBS effectively. These ongoing innovations are driving the Guillain-Barre syndrome diagnostics market expansion.

Increasing funding for medical research has significantly impacted the Guillain-Barre Syndrome diagnostics market trends. Governments, private organizations, and healthcare institutions are investing more resources into studying GBS, its causes, and improving diagnostic efficiency. These investments have led to the development of new methods, tools, and technologies that improve accuracy and reduce diagnosis time. Research funding has also deepened the understanding of the disease, leading to more effective detection strategies. Financial support for GBS research continues to drive the availability of advanced diagnostic solutions, making early detection and treatment more accessible to patients.

Guillain-Barre Syndrome Diagnostics Market Report Highlights

Based on end use, the hospital and clinics segment dominated the Guillain-Barre syndrome diagnostics market share in 2024 due to the availability of the required resources for the diagnosis of GBS.

The lumber puncture segment, by test, is expected to witness the fastest growth during the forecast period as it is a critical test that helps diagnose GBS by analyzing the cerebrospinal fluid for elevated protein levels.

In 2024, North America dominated the GBS diagnostics market revenue share, driven by advanced healthcare infrastructure and high awareness of rare diseases.

Asia Pacific is expected to record a significant share during the forecast period, due to improving healthcare infrastructure and increasing awareness of rare diseases.

A few global key market players are Alpine Biomed; Bionen Medical Devices; Cadwell Industries, Inc; Deymed Diagnostic; EMS Biomedical; Medtronic plc; Natus Medical Incorporated; Neurosoft; Nihon Kohden Corporation; and Rochester Electro-Medical, Inc.

Polaris Market Research has segmented the Guillain-Barre syndrome diagnostics market report on the basis of test, end use, and region:

By Test (Revenue - USD Million, 2020-2034)

  • Lumbar Puncture
  • Nerve Conduction
  • Electromyography
  • Other

By End Use (Revenue - USD Million, 2020-2034)

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Guillain-Barre Syndrome Diagnostics Market Insights

  • 4.1. Guillain-Barre Syndrome Diagnostics Market - Market Snapshot
  • 4.2. Guillain-Barre Syndrome Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Geriatric Population
      • 4.2.1.2. Rising Prevalence of Guillain-Barre Syndrome
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of Skilled Workforce
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Guillain-Barre Syndrome Diagnostics Market End Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Guillain-Barre Syndrome Diagnostics Market, by Test

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • 5.3. Lumbar Puncture
    • 5.3.1. Global Guillain-Barre Syndrome Diagnostics Market, by Lumbar Puncture, by Region, 2020-2034 (USD Million)
  • 5.4. Nerve Conduction
    • 5.4.1. Global Guillain-Barre Syndrome Diagnostics Market, by Nerve Conduction, by Region, 2020-2034 (USD Million)
  • 5.5. Electromyography
    • 5.5.1. Global Guillain-Barre Syndrome Diagnostics Market, by Electromyography, by Region, 2020-2034 (USD Million)
  • 5.6. Other
    • 5.6.1. Global Guillain-Barre Syndrome Diagnostics Market, by Other, by Region, 2020-2034 (USD Million)

6. Global Guillain-Barre Syndrome Diagnostics Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 6.3. Hospitals and Clinics
    • 6.3.1. Global Guillain-Barre Syndrome Diagnostics Market, by Hospitals and Clinics, by Region, 2020-2034 (USD Million)
  • 6.4. Diagnostic Laboratories
    • 6.4.1. Global Guillain-Barre Syndrome Diagnostics Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Guillain-Barre Syndrome Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Guillain-Barre Syndrome Diagnostics Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Guillain-Barre Syndrome Diagnostics Market Assessment, By Geography, 2020-2034 (USD Million)
  • 7.3. Guillain-Barre Syndrome Diagnostics Market - North America
    • 7.3.1. North America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 7.3.2. North America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.3.3. Guillain-Barre Syndrome Diagnostics Market - U.S.
      • 7.3.3.1. U.S.: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.3.3.2. U.S.: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.3.4. Guillain-Barre Syndrome Diagnostics Market - Canada
      • 7.3.4.1. Canada: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.3.4.2. Canada: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 7.4. Guillain-Barre Syndrome Diagnostics Market - Europe
    • 7.4.1. Europe: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 7.4.2. Europe: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.3. Guillain-Barre Syndrome Diagnostics Market - UK
      • 7.4.3.1. UK: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.3.2. UK: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.4. Guillain-Barre Syndrome Diagnostics Market - France
      • 7.4.4.1. France: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.4.2. France: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.5. Guillain-Barre Syndrome Diagnostics Market - Germany
      • 7.4.5.1. Germany: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.5.2. Germany: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.6. Guillain-Barre Syndrome Diagnostics Market - Italy
      • 7.4.6.1. Italy: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.6.2. Italy: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.7. Guillain-Barre Syndrome Diagnostics Market - Spain
      • 7.4.7.1. Spain: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.7.2. Spain: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.8. Guillain-Barre Syndrome Diagnostics Market - Netherlands
      • 7.4.8.1. Netherlands: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.8.2. Netherlands: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.9. Guillain-Barre Syndrome Diagnostics Market - Russia
      • 7.4.9.1. Russia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.9.2. Russia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.10. Guillain-Barre Syndrome Diagnostics Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.10.2. Rest of Europe: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 7.5. Guillain-Barre Syndrome Diagnostics Market - Asia Pacific
    • 7.5.1. Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 7.5.2. Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.3. Guillain-Barre Syndrome Diagnostics Market - China
      • 7.5.3.1. China: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.3.2. China: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.4. Guillain-Barre Syndrome Diagnostics Market - India
      • 7.5.4.1. India: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.4.2. India: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.5. Guillain-Barre Syndrome Diagnostics Market - Malaysia
      • 7.5.5.1. Malaysia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.5.2. Malaysia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.6. Guillain-Barre Syndrome Diagnostics Market - Japan
      • 7.5.6.1. Japan: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.6.2. Japan: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.7. Guillain-Barre Syndrome Diagnostics Market - Indonesia
      • 7.5.7.1. Indonesia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.7.2. Indonesia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.8. Guillain-Barre Syndrome Diagnostics Market - South Korea
      • 7.5.8.1. South Korea: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.8.2. South Korea: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.9. Guillain-Barre Syndrome Diagnostics Market - Australia
      • 7.5.9.1. Australia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.9.2. Australia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.10. Guillain-Barre Syndrome Diagnostics Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.10.2. Rest of Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 7.6. Guillain-Barre Syndrome Diagnostics Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 7.6.2. Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.6.3. Guillain-Barre Syndrome Diagnostics Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.6.3.2. Saudi Arabia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.6.4. Guillain-Barre Syndrome Diagnostics Market - UAE
      • 7.6.4.1. UAE: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.6.4.2. UAE: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.6.5. Guillain-Barre Syndrome Diagnostics Market - Israel
      • 7.6.5.1. Israel: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.6.5.2. Israel: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.6.6. Guillain-Barre Syndrome Diagnostics Market - South Africa
      • 7.6.6.1. South Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.6.6.2. South Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.6.7. Guillain-Barre Syndrome Diagnostics Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.6.7.2. Rest of Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 7.7. Guillain-Barre Syndrome Diagnostics Market - Latin America
    • 7.7.1. Latin America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 7.7.2. Latin America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.7.3. Guillain-Barre Syndrome Diagnostics Market - Mexico
      • 7.7.3.1. Mexico: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.7.3.2. Mexico: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.7.4. Guillain-Barre Syndrome Diagnostics Market - Brazil
      • 7.7.4.1. Brazil: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.7.4.2. Brazil: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.7.5. Guillain-Barre Syndrome Diagnostics Market - Argentina
      • 7.7.5.1. Argentina: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.7.5.2. Argentina: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.7.6. Guillain-Barre Syndrome Diagnostics Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.7.6.2. Rest of Latin America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Alpine Biomed
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Bionen Medical Devices
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Cadwell Industries, Inc
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Deymed Diagnostic
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. EMS Biomedical
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Medtronic plc
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Natus Medical Incorporated
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Neurosoft
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Nihon Kohden Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Rochester Electro-Medical, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development

List of Tables:

  • Table 1 Global Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 2 Global Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 3 North America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 4 North America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 5 U.S.: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 6 U.S.: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 7 Canada: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 8 Canada: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 9 Europe: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 10 Europe: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 11 UK: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 12 UK: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 13 France: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 14 France: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 15 Germany: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 16 Germany: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 17 Italy: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 18 Italy: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 19 Spain: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 20 Spain: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 21 Netherlands: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 22 Netherlands: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 23 Russia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 24 Russia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 25 Rest of Europe: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 26 Rest of Europe: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 27 Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 28 Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 29 China: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 30 China: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 31 India: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 32 India: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 33 Malaysia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 34 Malaysia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 35 Japan: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 36 Japan: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 37 Indonesia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 38 Indonesia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 39 South Korea: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 40 South Korea: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 41 Australia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 42 Australia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 43 Rest of Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 44 Rest of Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 45 Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 46 Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 47 Saudi Arabia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 48 Saudi Arabia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 49 UAE: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 50 UAE: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 51 Israel: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 52 Israel: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 53 South Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 54 South Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 55 Rest of Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 56 Rest of Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 57 Latin America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 58 Latin America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 59 Mexico: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 60 Mexico: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 61 Brazil: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 62 Brazil: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 63 Argentina: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 64 Argentina: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 65 Rest of Latin America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 66 Rest of Latin America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Guillain-Barre Syndrome Diagnostics Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Test
  • Figure 7. Global Guillain-Barre Syndrome Diagnostics Market, by Test, 2024 & 2034 (USD Million)
  • Figure 8. Market by End Use
  • Figure 9. Global Guillain-Barre Syndrome Diagnostics Market, by End Use, 2024 & 2034 (USD Million)